Colorado's highest court ruled Monday that Children's Hospital Colorado must resume prescribing puberty blockers and hormonal therapy to patients under 18, overriding the hospital's decision to pause those treatments after the federal government warned they could cost institutions their Medicaid funding.
The 5-2 decision sided with four transgender-identifying patients who, through their parents, sued the hospital under Colorado's anti-discrimination law. The majority held that cutting off the medications posed "irreparable harm" to the minor patients, and that this risk outweighed whatever financial consequences the hospital might face from Washington.
The ruling lands squarely in the middle of a widening clash between the Trump administration's effort to protect children from experimental medical interventions and a network of state courts, blue-state attorneys general, and activist litigants determined to keep the pipeline open. For parents and taxpayers who believe minors should not receive life-altering hormonal treatments, Monday's order is a stark reminder that progressive state courts can still override federal health guidance, and force hospitals to comply.
Justice William Hood III wrote the majority opinion. Fox News Digital reported that Hood framed the question as a balancing test between concrete patient harm and speculative institutional risk:
"We conclude that the actual immediate and irreparable harm to petitioners outweighs the speculative harm CHC may face if the federal government further acts against it."
Two justices dissented. The ruling effectively treats the hospital's pause, a direct response to a federal warning about Medicaid money, as unlawful discrimination under state law.
Children's Hospital Colorado, described as one of the top children's hospitals in the nation, offered a cautious response. A hospital spokesperson told Fox News Digital:
"Children's Hospital Colorado is reviewing the court's ruling and assessing our next steps. While we do not have updates to share at this time, we will provide guidance in the near future."
That careful language suggests the hospital may weigh an appeal or seek federal guidance before restarting treatments. Fox News Digital also reached out to HHS for comment, but no response was reported.
The chain of events began in December, when the U.S. Department of Health and Human Services issued a declaration warning that hospitals offering puberty blockers and hormonal therapy to patients under 18 could lose federal Medicaid funding. HHS Secretary Robert F. Kennedy Jr. framed the move as a matter of scientific integrity and child protection.
Kennedy stated at the time: "On my watch, HHS will stand for radical transparency and informed consent." He added:
"We follow the evidence. We employ gold standard science. We honor the moral obligation to do no harm. There is divine worth in every person. It shines most brightly in our children that was commanded us to protect them."
Children's Hospital Colorado responded to that declaration by pausing the treatments, a reasonable institutional decision for any hospital that depends on federal Medicaid dollars. The hospital did not act out of animus. It acted out of financial prudence.
But four families filed suit, arguing the pause violated Colorado anti-discrimination law. The state supreme court agreed with them.
Colorado's ruling did not happen in isolation. In March, U.S. District Judge Mustafa Kasubhai, a Biden appointee based in Oregon, ruled that Kennedy exceeded his authority and failed to follow required administrative procedures when HHS issued the December declaration. Kasubhai's order granted preliminary relief to health professionals who provide these treatments and prevents HHS from enforcing the declaration for now.
Meanwhile, Colorado was one of 19 states that filed a lawsuit against the Trump administration and Kennedy over the proposal. That coalition of blue states has treated the federal effort to protect minors from irreversible medical interventions as a civil-rights violation rather than a safeguard.
The broader legal landscape on gender-related policies for minors continues to shift. The U.S. Supreme Court recently struck down California's transgender secrecy law in a 6-3 ruling that affirmed parental rights, a decision that cut in exactly the opposite direction from what the Colorado court did Monday.
That tension matters. Federal courts and the nation's highest court have increasingly recognized that parents have a right to know what is happening to their children. Yet the Colorado Supreme Court's ruling effectively compels a hospital to administer hormonal treatments to minors over the objections of the federal health agency responsible for setting national standards.
The financial pressure on Children's Hospital Colorado is real. If HHS enforces its Medicaid funding warning, the hospital could face devastating revenue losses. If the hospital complies with the Colorado Supreme Court order, it risks running afoul of federal policy. The institution is caught between two governments pulling in opposite directions.
That bind is not accidental. Progressive litigants and state courts have learned that they can weaponize anti-discrimination statutes to override federal health guidance, forcing hospitals to choose between state court orders and federal funding rules. The hospital becomes the hostage.
Taxpayers, meanwhile, are left funding treatments that the nation's top health official has called inconsistent with sound medical evidence. Kennedy's HHS has argued that the evidence base for puberty blockers and cross-sex hormones in minors does not meet the "gold standard" threshold. Multiple European countries, including the United Kingdom, Sweden, and Finland, have already pulled back from these interventions for children, though those developments fall outside the scope of Monday's ruling.
Parental rights cases involving gender policies in schools have also been working their way toward the Supreme Court, raising the prospect that the justices may eventually have to resolve the contradiction between state-level mandates and federal authority on this issue.
While Colorado's court was ordering one hospital to resume treatments, another major institution was shutting them down. NYU Langone Health ended its Transgender Youth Health Program, citing the departure of a medical director and the shifting regulatory environment. The contrast is instructive.
NYU Langone made an institutional judgment that the medical and legal ground had shifted enough to warrant closing the program. Children's Hospital Colorado tried to make the same kind of prudent calculation, and got hauled into court for it.
The Colorado ruling does not just affect one hospital. It sends a signal to every medical institution in the state: pause these treatments, and you may face a lawsuit. Continue them, and you may lose federal funding. That is not a workable framework. It is a legal trap.
The Supreme Court has shown increasing willingness to intervene when state policies on gender and minors collide with constitutional rights. The Court reinstated an injunction against California's secret gender transition policies in schools, another sign that the justices see limits on what states can impose in this arena.
Children's Hospital Colorado said it is "assessing next steps." That language leaves room for an appeal to the U.S. Supreme Court, a request for federal intervention, or compliance under protest. The hospital's legal team will have to weigh whether the Colorado ruling can coexist with Judge Kasubhai's separate order blocking HHS enforcement, and whether the federal government will step in to clarify the situation.
The broader fight is far from settled. Kennedy and the Trump administration have made clear since the start of the second term that restricting these treatments for minors is a priority. Nineteen states have lined up on the other side. Federal and state courts are issuing conflicting orders. And hospitals, institutions that exist to treat sick children, not to serve as battlegrounds for culture wars, are stuck in the middle.
The legal questions are real, and the Supreme Court's willingness to engage with politically charged disputes suggests these cases will not stay in state courts forever. The question is whether the justices will let a patchwork of state rulings force hospitals to administer treatments that the federal government's own health agency says lack adequate scientific support.
Five justices in Denver just told a children's hospital it must inject minors with puberty blockers whether the federal government approves or not. If that doesn't demand Supreme Court review, it's hard to imagine what would.